Aktien Sensor

Zimmer Biomet Holdings Inc. has secured its first iodine-technology orthopedic implant approval in Japan, a regulatory milestone that is expected to bolster the company’s competitive standing in the global market and drive revenue growth.

Pfizer Inc. is navigating a complex landscape of opportunity and risk, with its stock performance and valuation influenced by factors such as its robust pipeline, litigation exposure, regulatory developments, and global trade policies.

Danaher Corporation, a diversified healthcare company, faces challenges in revenue growth, patent expirations, and governance scrutiny, but strategic moves and investments in digital diagnostics and AI-powered analytics could help maintain its compe…

Jiangsu Hengrui Pharmaceuticals Co Ltd has secured a licensing agreement with Glenmark Specialty for the novel therapeutic agent SHR-A1811, a treatment for HER2-positive non-small cell lung cancer, which is expected to boost the company’s revenue an…

Bristol-Myers Squibb Co. has reported positive clinical and reimbursement developments, including encouraging data from a late-stage clinical study and a favorable reimbursement recommendation for its OPDIVO subcutaneous formulation in Quebec, which…

Siemens Healthineers AG continues to solidify its position as a leader in medical technology through strategic partnerships, talent acquisitions, and a focus on core product categories, despite a volatile macroeconomic environment.

STERIS PLC, a global infection prevention and procedural products company, has seen its shares more than double in value over the past two years, driven by strong operational performance, strategic innovation, and a favorable reimbursement climate, …

Alcon AG’s share price declined amid market volatility, raising concerns about the company’s valuation and the pending acquisition of STAAR Surgical, but its long-term prospects remain strong due to its position in the growing ophthalmic device mark…

Revvity Inc. has partnered with Profluent to develop and commercialize AI-enhanced adenine deaminase-based Pin-point base editing systems, aiming to deliver precise and high-throughput genome editing capabilities for researchers and clinicians.

Demant A/S, a leading Danish provider of hearing solutions, has seen its share price decline modestly due to broader market weakness, but its strong fundamentals and innovation pipeline are expected to underpin medium-term resilience.